Overview

The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder

Status:
Withdrawn
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will increase HRV at the end of the treatment.
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
S 20098